Australian Prescriber

📢 The new release of Australian Prescriber covers two challenges in clinical practice: medicine shortages and inhaler devices for people with #asthma or #COPD. Also, the issue features a reflection on community #antimicrobial prescribing as the AURA surveillance program reaches almost 10 years of data! Finally, as always, you can find a brief commentary on several new drugs marketed in #Australia. 👉 Dive in and stay informed: https://bit.ly/4hbHz7h #Healthcare #PatientCare #MedicineUpdates 

Vapes (e-cigarettes) in Australia can now only be lawfully supplied from pharmacies, with a prescription or as a Schedule 3 medicine. This article provides practical guidance on the prescription and supply of therapeutic vapes to support people who are smoking or vaping: https://bit.ly/3DdNKYW Quit Centre #Ecigarettes #Vapes #Vaping #Smokingcessation

The December issue of #AustralianPrescriber is out⏩ https://bit.ly/4gz0yYd! The new issue covers therapeutic #vapes, antiphospholipid syndrome, establishing a national standard for chronic obstructive pulmonary disease (#COPD), pharmacovigilance in Australia, our annual #top10drugs feature and more. What a year 2024 has been? A BIG thank you to all our authors, peer reviewers and wonderful readers! Enjoy the festive season. See you in 2025!

How has the pandemic impacted antibiotic use in Australia? 🎧 Listen to the latest #AustralianPrescriber #podcast episode as Dhineli Perera speaks with Professor John Turnidge, Senior Medical Advisor for Antimicrobial Use and Resistance at the Australian Commission on Safety and Quality in Health Care. They reflect on ten years of Antimicrobial Use and Resistance in Australia 👉 https://bit.ly/3OGMRdU @ACSQHC #Antimicrobials #AMR #AMS #Australia

🎧 Just released: Laura Beaton interviews Debbie Rigby from the National Asthma Council Australia to discuss her article on inhaler device selection for asthma and #COPD patients. Debbie explores the benefits, limitations, and environmental considerations of various inhalers and how to help patients use them effectively. Listen to the podcast episode: https://bit.ly/4fsWGbe Read Debbie’s article in Australian Prescriber: https://bit.ly/3UXvRUe #AsthmaManagement #COPD #HealthcarePodcast #PatientCare #InhalerGuidance

We’re looking for a Clinical Editor for Australian Prescriber! The role involves developing and delivering Australian Prescriber content, as well as collaboration with the AP Editorial team, the wider Publishing team, the Production team, authors, reviewers and the Editorial Advisory Committee. 📣 If this sounds like you, or someone you know, apply now: https://bit.ly/3UYk2gF Applications close 5pm, Sunday 1 December 2024. #NorthMelbourne #JobAd #AustralianPrescriber #Healthcare

The latest issue of #AustralianPrescriber highlights several new drugs. ⚪ Avacopan: for antineutrophil cytoplasmic antibody–associated vasculitis. Clascoterone: a topical treatment for moderate to severe #acne. ⚪Fezolinetant: an oral nonhormonal treatment alternative to systemic #menopausal hormone therapy. ⚪And more. Check out the October issue to stay informed: https://bit.ly/3Z39rTZ #NewTreatments #PatientCare #AcneCare #MenopauseSupport #WomensHealth #PharmacyUpdates #MedicalNews

🔊 New #Podcast Alert! Join Jo Cheah as she speaks with Tom Simpson FANZCAP, President, and Jerry Yik, Head of Policy and Advocacy at Advanced Pharmacy Australia, on the ongoing challenges of medicine shortages in Australia. In this episode, Tom and Jerry share key strategies on how to identify, communicate, and manage shortages to ensure the best patient care. Listen now: https://bit.ly/48BwMiZ 📖 Read the article in Australian Prescriber to get a more in-depth insight: https://bit.ly/3O3XWpe #Healthcare #PharmacyAustralia #MedicineShortages #HealthcareProfessionals #PatientCare #AustralianPrescriber

🔔 All practitioners should be aware of the possibility of immune-related adverse events in patients with cancer treated with immune checkpoint inhibitors. These adverse events can affect multiple organs and may appear during or after stopping therapy. The majority are reversible if identified and treated early – if suspected, notify the patient’s cancer treatment team early. Read more about it: https://bit.ly/3O03u43 #Oncology #CancerTreatment #HealthcareProfessionals #MedicalSafety #PatientCare #Immunotherapy #Pharmacovigilance #ClinicalAwareness

The COVID-19 pandemic coincided with a significant reduction in systemic #antibacterial use in the community; however, #antimicrobial use in residents of aged-care homes remains at a high level. What do these trends tells us, and what further work is required to reduce inappropriate antimicrobial use long term? Learn more in #AustralianPrescriber: https://buff.ly/3YvUp7Y Australian Commission on Safety and Quality in Health Care #AgedCare #HealthcareCommunity #HealthcareTrends #AntimicrobialUse #PatientSafety #PublicHealth #CommunityHealth